71 results
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
warrants
S-16
Material United States federal income tax consequences for investors in our common stock and pre-funded warrants
S-18
Underwriting
S-25 … warrants.
S-17
Material United States federal income tax consequences for investors in our common stock and pre-funded warrants
The following
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
Dividend policy
S-13
Dilution
S-14
Description of pre-funded warrants
S-16
Material United States federal income tax consequences for investors in our … , including any voting rights, until such pre-funded warrant holders exercise their pre-funded warrants.
S-17
Material United States federal income tax
424B4
8vtwilnp7j
5 Mar 21
Prospectus supplement with pricing info
4:07pm
DRS
waepeint39ba is
22 Feb 21
Draft registration statement
12:00am
10-Q
bnzwq33
14 Oct 20
Quarterly report
4:02pm
S-1
v1wslj
2 Jul 20
IPO registration
4:04pm
DRS
35bcgup445 9az1hp4c
5 May 20
Draft registration statement
12:00am
424B4
8xhokil
24 Jul 20
Prospectus supplement with pricing info
4:06pm
10-K
59b89vaficad 72yh
16 Feb 21
Annual report
4:11pm
DRS/A
m5fg9 2wqops
10 Jun 20
Draft registration statement (amended)
12:00am